Glucosamine May Accelerate Cognitive Decline in Individuals with Early Memory Loss

A new study published in Nature Metabolism suggests that glucosamine, a common over-the-counter supplement for joint pain, may accelerate cognitive decline in people with mild cognitive impairment. The research found that individuals in the early stages of memory loss who were taking glucosamine were 25% more likely to progress to full Alzheimer's disease.